Deficiencies in key vitamins are frequently observed in individuals suffering from Alzheimer’s disease, according to findings from a study conducted by Italian researchers and published in the journal Frontiers in Nutrition. Specifically, the elements in question fall within groups A, B, C, and D.
The research team established that vitamins B6, B9, and B12 possess the ability to slow the rate of brain volume reduction in persons experiencing mild cognitive impairment. Furthermore, elements D, C, and E contribute to reducing both inflammatory responses and oxidative processes. Experts pointed out that the benefits of these vitamins in managing this specific illness are greatest when they are administered together, but a prerequisite for any combined regimen is obtaining professional medical advice first.
It was previously noted that a standard, seasonal influenza vaccination might play a role in lowering the likelihood of developing dementia. Scientists concluded that the vaccine aids in mitigating the probability of vascular and inflammatory events that are implicated in the decline of cognitive abilities.
About the Author
